Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Cardiometabolic Beat Podcast - The Intersection of MASH and Cardiometabolic Risk -  Part 1

The Intersection of MASH and Cardiometabolic Risk - Part 1

06/24/24 • 36 min

Cardiometabolic Beat Podcast
Case #1: A 37-Year-Old Man with Incidental Hepatic Steatosis on Abdominal Ultrasound During this Ace the Case activity, you will learn about risk factors for metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction–associated steatohepatitis (MASH), and advanced fibrosis, as well as the current and emerging noninvasive liver assessment tests.
plus icon
bookmark
Case #1: A 37-Year-Old Man with Incidental Hepatic Steatosis on Abdominal Ultrasound During this Ace the Case activity, you will learn about risk factors for metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction–associated steatohepatitis (MASH), and advanced fibrosis, as well as the current and emerging noninvasive liver assessment tests.

Previous Episode

undefined - Case #3: A 54-Year-Old South Asian Male with a History of Cardiac Percutaneous Intervention

Case #3: A 54-Year-Old South Asian Male with a History of Cardiac Percutaneous Intervention

This three part series consists of 3 cases that illustrate important concepts in managing patients with familial hypercholesterolemia, patients with hyperlipidemia and cardiometabolic comorbidities, and patient with South Asian descent with increased risk of ASCVD and a history of percutaneous Intervention. The cases are designed to be quick and offer high-level takeaways and pearls. In this podcast, experts will discuss the following case: A 54-Year-Old South Asian Male with a History of Cardiac Percutaneous Intervention

Next Episode

undefined - The Intersection of MASH and Cardiometabolic Risk - Part 2

The Intersection of MASH and Cardiometabolic Risk - Part 2

Case #2: A 60-Year-Old Type 2 Diabetic Woman with MASH and F3 Liver Fibrosis This Ace the Case activity will review a detailed case discussion on the latest clinical care guidelines and emerging treatments for MASH. Participants will explore novel treatment targets and the most recent clinical data for treating patients with MASH and cardiometabolic comorbidities. Gain practical insights for individualizing patient care plans in your practice. Don’t miss this opportunity to enhance your expertise and improve patient outcomes

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/cardiometabolic-beat-podcast-622122/the-intersection-of-mash-and-cardiometabolic-risk-part-1-82193590"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to the intersection of mash and cardiometabolic risk - part 1 on goodpods" style="width: 225px" /> </a>

Copy